إعلان مُمول
PV Management in 2025: The Era of Expanding Alternatives
Polycythemia Vera (PV), a chronic myeloproliferative neoplasm characterized by the uncontrolled overproduction of red blood cells (erythrocytosis), is currently at a critical inflection point. In 2025, the polycythemia vera treatment market is defined by fierce competition between established therapies and compelling novel candidates, suggesting a major paradigm shift in patient management is...
0 التعليقات 0 المشاركات 58 مشاهدة 0 معاينة
إعلان مُمول
إعلان مُمول
إعلان مُمول